|
OMIM |
Link |
Information gain |
01 |
|
PCD
|
[NCBI]
|
0.00931413
|
|
|
immune defect due to absence of thymus
|
[NCBI]
|
0.00428013
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
0.00293727
|
|
|
FA
|
[NCBI]
|
0.00267869
|
|
|
reticular dysgenesia
|
[NCBI]
|
0.0023678
|
|
|
SLE
|
[NCBI]
|
0.00211214
|
|
|
mutagen sensitivity
|
[NCBI]
|
0.00207538
|
|
|
AT
|
[NCBI]
|
0.00175132
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
0.0015772
|
|
|
ADA
|
[NCBI]
|
0.00136719
|
|
|
CDAN2
|
[NCBI]
|
0.00129361
|
|
|
neutropenia, chronic familial
|
[NCBI]
|
0.00107922
|
|
|
DFNA25
|
[NCBI]
|
0.00103593
|
|
|
CF
|
[NCBI]
|
0.000731182
|
|
|
breast cancer, 11-22 translocation associated
|
[NCBI]
|
0.000727142
|
|
|
hyperimmunoglobulin e-recurrent infection syndrome, autosomal recessive
|
[NCBI]
|
0.000727142
|
|
|
EC1
|
[NCBI]
|
0.000727142
|
|
|
behcet syndrome
|
[NCBI]
|
0.00072667
|
|
|
IL2
|
[NCBI]
|
0.000724488
|
|
|
ALPS
|
[NCBI]
|
0.000704942
|
|
|
small cell cancer of the lung
|
[NCBI]
|
0.000656019
|
|
|
WAS
|
[NCBI]
|
0.000653557
|
|
|
SRS
|
[NCBI]
|
0.000652622
|
|
|
lymphangiectasia, intestinal
|
[NCBI]
|
0.000611969
|
|
|
RA
|
[NCBI]
|
0.000587088
|
|
|
BLM
|
[NCBI]
|
0.000539453
|
|
|
CYP1A1
|
[NCBI]
|
0.000539103
|
|
|
TKCR
|
[NCBI]
|
0.00053795
|
|
|
WT3
|
[NCBI]
|
0.000483477
|
|
|
EGF
|
[NCBI]
|
0.000479606
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
0.00045585
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
0.00044273
|
|
|
aryl hydrocarbon hydroxylase inducibility
|
[NCBI]
|
0.000442006
|
|
|
IBD2
|
[NCBI]
|
0.000440517
|
|
|
PAND1
|
[NCBI]
|
0.000440517
|
|
|
IGAD1
|
[NCBI]
|
0.000405163
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.000390384
|
|
|
HLP
|
[NCBI]
|
0.000375217
|
|
|
VEGF
|
[NCBI]
|
0.000372913
|
|
|
BL
|
[NCBI]
|
0.00031266
|
|
|
CJD
|
[NCBI]
|
0.000306376
|
|
|
ATHS
|
[NCBI]
|
0.000306288
|
|
|
WRN
|
[NCBI]
|
0.000301924
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.000288078
|
|
|
IDDM
|
[NCBI]
|
0.000282769
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
0.000279387
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
0.000258342
|
|
|
TNFSF6
|
[NCBI]
|
0.00025694
|
|
|
LIP
|
[NCBI]
|
0.000234423
|
|
|
AD
|
[NCBI]
|
0.000229607
|
|
|
RBS
|
[NCBI]
|
0.000220526
|
|
|
DCK
|
[NCBI]
|
0.000211123
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
0.000210974
|
|
|
SCIDX1
|
[NCBI]
|
0.000204099
|
|
|
immunodeficiency, x-linked, with deficiency of 115,000 dalton surface glycoprotein
|
[NCBI]
|
0.000200531
|
|
|
PLT1
|
[NCBI]
|
0.000200531
|
|
|
bare lymphocyte syndrome, type i
|
[NCBI]
|
0.000200531
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
0.000196878
|
|
|
succinic semialdehyde dehydrogenase deficiency
|
[NCBI]
|
0.000191395
|
|
|
CHS
|
[NCBI]
|
0.000189787
|
|
|
NPY
|
[NCBI]
|
0.000189051
|
|
|
NGFB
|
[NCBI]
|
0.000188997
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000182585
|
|
|
TNF
|
[NCBI]
|
0.000181149
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
0.000180987
|
|
|
CVID
|
[NCBI]
|
0.000171583
|
|
|
diabetes mellitus, transient neonatal, 1
|
[NCBI]
|
0.000169804
|
|
|
PTH
|
[NCBI]
|
0.000165135
|
|
|
CLN3
|
[NCBI]
|
0.000162978
|
|
|
mitochondrial complex ii deficiency
|
[NCBI]
|
0.000155044
|
|
|
GFAP
|
[NCBI]
|
0.000149328
|
|
|
AR
|
[NCBI]
|
0.000147319
|
|
|
immunodeficiency, partial combined, with absence of hla determinants and beta-2-microglobulin from lymphocytes
|
[NCBI]
|
0.000147263
|
|
|
surface antigen, glycoprotein 75
|
[NCBI]
|
0.000147263
|
|
|
holoprosencephaly
|
[NCBI]
|
0.000147147
|
|
|
TH
|
[NCBI]
|
0.000136003
|
|
|
pyruvate decarboxylase deficiency
|
[NCBI]
|
0.000135087
|
|
|
BDNF
|
[NCBI]
|
0.000134355
|
|
|
PCS
|
[NCBI]
|
0.000133589
|
|
|
PD
|
[NCBI]
|
0.000132949
|
|
|
AVP
|
[NCBI]
|
0.000131342
|
|
|
fragile site 17p12
|
[NCBI]
|
0.000123645
|
|
|
CRC
|
[NCBI]
|
0.00012293
|
|
|
RP
|
[NCBI]
|
0.000118853
|
|
|
holocarboxylase synthetase deficiency
|
[NCBI]
|
0.000117142
|
|
|
omenn syndrome
|
[NCBI]
|
0.000117142
|
|
|
MBP
|
[NCBI]
|
0.000113646
|
|
|
FRA16A
|
[NCBI]
|
0.000110195
|
|
|
CCK
|
[NCBI]
|
0.00010982
|
|
|
fragile site 10q25
|
[NCBI]
|
0.000107694
|
|
|
amyloidosis vi
|
[NCBI]
|
0.000107451
|
|
|
SELL
|
[NCBI]
|
0.000106315
|
|
|
LCP1
|
[NCBI]
|
0.000105672
|
|
|
EGFR
|
[NCBI]
|
0.00010163
|
|
|
BTHS
|
[NCBI]
|
0.000100733
|
|
|
sister chromatid exchange, frequency of
|
[NCBI]
|
0.000100256
|
|
|
acid phosphatase deficiency
|
[NCBI]
|
0.000100256
|
|
|
hla modifier
|
[NCBI]
|
0.000100256
|
|
|
lymphoblastic transformation, intrinsic defect in
|
[NCBI]
|
0.000100256
|
|
|
transaldolase deficiency
|
[NCBI]
|
0.000100256
|
|
|
blood group--abh antigen, type 2
|
[NCBI]
|
0.000100256
|
|
|
lymphoblastic transformation, inhibition of
|
[NCBI]
|
0.000100256
|
|
|
virus rd114 rna complementarity
|
[NCBI]
|
0.000100256
|
|
|
CDG1H
|
[NCBI]
|
0.000100256
|
|
|
xeroderma pigmentosum, autosomal dominant, mild
|
[NCBI]
|
0.000100256
|
|
|
mental retardation, buenos aires type
|
[NCBI]
|
0.000100256
|
|
|
HPRT1
|
[NCBI]
|
9.63656e-05
|
|
|
gout, hprt-related
|
[NCBI]
|
9.56646e-05
|
|
|
fragile site 2q11
|
[NCBI]
|
9.56646e-05
|
|
|
maple syrup urine disease
|
[NCBI]
|
9.52166e-05
|
|
|
HSAN3
|
[NCBI]
|
9.23421e-05
|
|
|
LPL
|
[NCBI]
|
8.71368e-05
|
|
|
nondisjunction
|
[NCBI]
|
8.60501e-05
|
|
|
PKS
|
[NCBI]
|
8.58976e-05
|
|
|
DNTT
|
[NCBI]
|
8.44172e-05
|
|
|
NPPA
|
[NCBI]
|
8.09423e-05
|
|
|
EDG1
|
[NCBI]
|
8.03444e-05
|
|
|
CLN1
|
[NCBI]
|
7.9376e-05
|
|
|
FANCB
|
[NCBI]
|
7.80792e-05
|
|
|
sc phocomelia syndrome
|
[NCBI]
|
7.80792e-05
|
|
|
halothane hepatitis
|
[NCBI]
|
7.80792e-05
|
|
|
TG
|
[NCBI]
|
7.75656e-05
|
|
|
PTK2
|
[NCBI]
|
7.4159e-05
|
|
|
HLA-DPA1
|
[NCBI]
|
7.39733e-05
|
|
|
LCK
|
[NCBI]
|
7.35414e-05
|
|
|
HGF
|
[NCBI]
|
7.2495e-05
|
|
|
hexokinase deficiency hemolytic anemia
|
[NCBI]
|
7.13016e-05
|
|
|
TNFRSF25
|
[NCBI]
|
6.88296e-05
|
|
|
CD
|
[NCBI]
|
6.85337e-05
|
|
|
phosphoribosylpyrophosphate synthetase superactivity
|
[NCBI]
|
6.84019e-05
|
|
|
DPP7
|
[NCBI]
|
6.65277e-05
|
|
|
EBVS1
|
[NCBI]
|
6.54309e-05
|
|
|
INSR
|
[NCBI]
|
6.41557e-05
|
|
|
STK10
|
[NCBI]
|
6.41477e-05
|
|
|
FANCC
|
[NCBI]
|
6.27856e-05
|
|
|
CLL
|
[NCBI]
|
6.21452e-05
|
|
|
SPHK2
|
[NCBI]
|
6.21363e-05
|
|
|
caspase 8 deficiency
|
[NCBI]
|
6.18139e-05
|
|
|
fucosidase regulator
|
[NCBI]
|
6.18139e-05
|
|
|
colchicine resistance
|
[NCBI]
|
6.18139e-05
|
|
|
craniosynostosis-microcephaly with chromosomal breakage and other abnormalities
|
[NCBI]
|
6.18139e-05
|
|
|
ragweed sensitivity
|
[NCBI]
|
6.18139e-05
|
|
|
corpus callosum, agenesis of, with abnormal genitalia
|
[NCBI]
|
6.18139e-05
|
|
|
pseudoacromegaly with severe insulin resistance
|
[NCBI]
|
6.18139e-05
|
|
|
aminoacylase 1 deficiency
|
[NCBI]
|
6.18139e-05
|
|
|
irak4 deficiency
|
[NCBI]
|
6.18139e-05
|
|
|
factor viii deficiency
|
[NCBI]
|
6.18139e-05
|
|
|
intrauterine growth retardation with increased mitomycin c sensitivity
|
[NCBI]
|
6.18139e-05
|
|
|
DMD
|
[NCBI]
|
6.04023e-05
|
|
|
THC1
|
[NCBI]
|
6.02731e-05
|
|
|
galactose epimerase deficiency
|
[NCBI]
|
6.02731e-05
|
|
|
SPDA1
|
[NCBI]
|
6.02731e-05
|
|
|
ACHE
|
[NCBI]
|
5.98273e-05
|
|
|
temporal arteritis
|
[NCBI]
|
5.95272e-05
|
|
|
CHAT
|
[NCBI]
|
5.86811e-05
|
|
|
ATM
|
[NCBI]
|
5.69874e-05
|
|
|
DKC
|
[NCBI]
|
5.65659e-05
|
|
|
GIST
|
[NCBI]
|
5.59737e-05
|
|
|
HD
|
[NCBI]
|
5.57774e-05
|
|
|
IFNG
|
[NCBI]
|
5.56927e-05
|
|
|
pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
|
[NCBI]
|
5.56906e-05
|
|
|
LAD
|
[NCBI]
|
5.47183e-05
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
5.39959e-05
|
|
|
APRT
|
[NCBI]
|
5.354e-05
|
|
|
IL2RG
|
[NCBI]
|
5.33758e-05
|
|
|
BWS
|
[NCBI]
|
5.32418e-05
|
|
|
ALD
|
[NCBI]
|
5.22881e-05
|
|
|
biotinidase deficiency
|
[NCBI]
|
5.15823e-05
|
|
|
CDG2C
|
[NCBI]
|
5.15823e-05
|
|
|
MDD
|
[NCBI]
|
5.09321e-05
|
|
|
RAG1
|
[NCBI]
|
5.09163e-05
|
|
|
PNPLA6
|
[NCBI]
|
5.04846e-05
|
|
|
SDHC
|
[NCBI]
|
5.04815e-05
|
|
|
IHG
|
[NCBI]
|
5.048e-05
|
|
|
ADAM28
|
[NCBI]
|
5.048e-05
|
|
|
XLRL
|
[NCBI]
|
5.048e-05
|
|
|
LRMP
|
[NCBI]
|
5.048e-05
|
|
|
IGHG1
|
[NCBI]
|
4.97715e-05
|
|
|
WBS
|
[NCBI]
|
4.95326e-05
|
|
|
ALPS2A
|
[NCBI]
|
4.78241e-05
|
|
|
CIDX
|
[NCBI]
|
4.78241e-05
|
|
|
CFEOM2
|
[NCBI]
|
4.78241e-05
|
|
|
sarcoidosis
|
[NCBI]
|
4.78241e-05
|
|
|
renal tubular acidosis, proximal, with ocular abnormalities and mental retardation
|
[NCBI]
|
4.78241e-05
|
|
|
MRX63
|
[NCBI]
|
4.78241e-05
|
|
|
hyperferritinemia-cataract syndrome
|
[NCBI]
|
4.78241e-05
|
|
|
sodium-potassium-atpase activity of red cell
|
[NCBI]
|
4.78241e-05
|
|
|
CRH
|
[NCBI]
|
4.76622e-05
|
|
|
GCCR
|
[NCBI]
|
4.64549e-05
|
|
|
PAEP
|
[NCBI]
|
4.62009e-05
|
|
|
PTPRC
|
[NCBI]
|
4.56588e-05
|
|
|
fucosidosis
|
[NCBI]
|
4.56588e-05
|
|
|
PPARA
|
[NCBI]
|
4.45964e-05
|
|
|
PREP
|
[NCBI]
|
4.43488e-05
|
|
|
HLA-A
|
[NCBI]
|
4.39356e-05
|
|
|
3-@hydroxy-3-methylglutaryl-coa lyase deficiency
|
[NCBI]
|
4.31805e-05
|
|
|
APC
|
[NCBI]
|
4.29024e-05
|
|
|
FTH1
|
[NCBI]
|
4.17149e-05
|
|
|
IKZF1
|
[NCBI]
|
4.17149e-05
|
|
|
BTK
|
[NCBI]
|
4.16314e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
4.16198e-05
|
|
|
B2M
|
[NCBI]
|
4.13398e-05
|
|
|
BMD
|
[NCBI]
|
4.1025e-05
|
|
|
RB1
|
[NCBI]
|
4.04152e-05
|
|
|
TAL1
|
[NCBI]
|
4.03534e-05
|
|
|
XCL1
|
[NCBI]
|
4.03534e-05
|
|
|
CS
|
[NCBI]
|
4.01663e-05
|
|
|
FMR1
|
[NCBI]
|
3.9854e-05
|
|
|
LSA
|
[NCBI]
|
3.92012e-05
|
|
|
WIPF1
|
[NCBI]
|
3.90829e-05
|
|
|
immunodeficiency with hyper-igm, type 3
|
[NCBI]
|
3.90319e-05
|
|
|
desmosterolosis
|
[NCBI]
|
3.90319e-05
|
|
|
dna, satellite, alpha type
|
[NCBI]
|
3.90319e-05
|
|
|
EDM3
|
[NCBI]
|
3.90319e-05
|
|
|
premature chromosome condensation with microcephaly and mental retardation
|
[NCBI]
|
3.90319e-05
|
|
|
wolfram syndrome, mitochondrial form
|
[NCBI]
|
3.90319e-05
|
|
|
ARMD7
|
[NCBI]
|
3.90319e-05
|
|
|
immunodeficiency with defective leukocyte and lymphocyte function and with response to histamine-1 antagonist
|
[NCBI]
|
3.90319e-05
|
|
|
achondroplasia, so-called, and severe combined immunodeficiency
|
[NCBI]
|
3.90319e-05
|
|
|
mucopolysaccharidosis type iiia
|
[NCBI]
|
3.85912e-05
|
|
|
IL4
|
[NCBI]
|
3.80383e-05
|
|
|
TS
|
[NCBI]
|
3.73788e-05
|
|
|
EPHX2
|
[NCBI]
|
3.69808e-05
|
|
|
DEAF1
|
[NCBI]
|
3.69808e-05
|
|
|
ESCO2
|
[NCBI]
|
3.69808e-05
|
|
|
TALDO1
|
[NCBI]
|
3.69808e-05
|
|
|
AK2
|
[NCBI]
|
3.69808e-05
|
|
|
COL9A3
|
[NCBI]
|
3.69808e-05
|
|
|
FKBP5
|
[NCBI]
|
3.69808e-05
|
|
|
NRAS
|
[NCBI]
|
3.67734e-05
|
|
|
SLC6A3
|
[NCBI]
|
3.66453e-05
|
|
|
CCAL2
|
[NCBI]
|
3.59865e-05
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
3.57909e-05
|
|
|
SPP1
|
[NCBI]
|
3.50043e-05
|
|
|
HOXB4
|
[NCBI]
|
3.44091e-05
|
|
|
FANCE
|
[NCBI]
|
3.44091e-05
|
|
|
IGKV
|
[NCBI]
|
3.44091e-05
|
|
|
ACADM
|
[NCBI]
|
3.31781e-05
|
|
|
CDA
|
[NCBI]
|
3.28735e-05
|
|
|
GSR
|
[NCBI]
|
3.28581e-05
|
|
|
mental retardation, fra12a type
|
[NCBI]
|
3.27083e-05
|
|
|
cystathioninuria
|
[NCBI]
|
3.27083e-05
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
3.27083e-05
|
|
|
asthma-related traits, susceptibility to, 1
|
[NCBI]
|
3.27083e-05
|
|
|
ARMD4
|
[NCBI]
|
3.27083e-05
|
|
|
OUBR
|
[NCBI]
|
3.27083e-05
|
|
|
LISX2
|
[NCBI]
|
3.27083e-05
|
|
|
gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to
|
[NCBI]
|
3.27083e-05
|
|
|
papilloma of choroid plexus
|
[NCBI]
|
3.27083e-05
|
|
|
adenylosuccinase deficiency
|
[NCBI]
|
3.27083e-05
|
|
|
CO
|
[NCBI]
|
3.27083e-05
|
|
|
growth hormone insensitivity with immunodeficiency
|
[NCBI]
|
3.27083e-05
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
3.27083e-05
|
|
|
AVSD2
|
[NCBI]
|
3.27083e-05
|
|
|
XPB
|
[NCBI]
|
3.27083e-05
|
|
|
EPO
|
[NCBI]
|
3.25087e-05
|
|
|
CCL21
|
[NCBI]
|
3.23224e-05
|
|
|
GART
|
[NCBI]
|
3.22551e-05
|
|
|
PGM2
|
[NCBI]
|
3.22551e-05
|
|
|
CD38
|
[NCBI]
|
3.22551e-05
|
|
|
RFC5
|
[NCBI]
|
3.20723e-05
|
|
|
UBE2D3
|
[NCBI]
|
3.20723e-05
|
|
|
TAX1BP2
|
[NCBI]
|
3.20723e-05
|
|
|
trophoblast-lymphocyte crossreactive antigen
|
[NCBI]
|
3.20723e-05
|
|
|
MXD3
|
[NCBI]
|
3.20723e-05
|
|
|
PPIL2
|
[NCBI]
|
3.20723e-05
|
|
|
S8
|
[NCBI]
|
3.20723e-05
|
|
|
IGLP1
|
[NCBI]
|
3.20723e-05
|
|
|
AP2A2
|
[NCBI]
|
3.20723e-05
|
|
|
IFI16
|
[NCBI]
|
3.20723e-05
|
|
|
A11
|
[NCBI]
|
3.20723e-05
|
|
|
lymphocyte cytosol polypeptide, 40-kd
|
[NCBI]
|
3.20723e-05
|
|
|
HOXC4
|
[NCBI]
|
3.20723e-05
|
|
|
IDH3B
|
[NCBI]
|
3.20723e-05
|
|
|
C19ORF10
|
[NCBI]
|
3.20723e-05
|
|
|
RAD52
|
[NCBI]
|
3.20723e-05
|
|
|
ZFP37
|
[NCBI]
|
3.20723e-05
|
|
|
RND2
|
[NCBI]
|
3.20723e-05
|
|
|
lymphocyte cytosol polypeptide, 49-kd
|
[NCBI]
|
3.20723e-05
|
|
|
lymphocyte cytosol polypeptide, 100-kd
|
[NCBI]
|
3.20723e-05
|
|
|
HSPA9B
|
[NCBI]
|
3.20723e-05
|
|
|
PSMB8
|
[NCBI]
|
3.20723e-05
|
|
|
alg8, s. cerevisiae, homolog of
|
[NCBI]
|
3.20723e-05
|
|
|
COPG2IT1
|
[NCBI]
|
3.20723e-05
|
|
|
RAB5B
|
[NCBI]
|
3.20723e-05
|
|
|
IGKC
|
[NCBI]
|
3.20169e-05
|
|
|
DGS
|
[NCBI]
|
3.19018e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
3.15639e-05
|
|
|
CES
|
[NCBI]
|
3.14662e-05
|
|
|
OCRL
|
[NCBI]
|
3.13471e-05
|
|
|
TGD
|
[NCBI]
|
3.13471e-05
|
|
|
KLK3
|
[NCBI]
|
3.12375e-05
|
|
|
FHIT
|
[NCBI]
|
3.11996e-05
|
|
|
CD44
|
[NCBI]
|
3.04185e-05
|
|
|
CD81
|
[NCBI]
|
3.04044e-05
|
|
|
NP
|
[NCBI]
|
2.98296e-05
|
|
|
ITGB2
|
[NCBI]
|
2.98296e-05
|
|
|
TRPS2
|
[NCBI]
|
2.97999e-05
|
|
|
coproporphyria
|
[NCBI]
|
2.96707e-05
|
|
|
SLC3A2
|
[NCBI]
|
2.96707e-05
|
|
|
BCNS
|
[NCBI]
|
2.93792e-05
|
|
|
ICAM1
|
[NCBI]
|
2.89539e-05
|
|
|
TNFSF15
|
[NCBI]
|
2.87843e-05
|
|
|
RNR1
|
[NCBI]
|
2.87843e-05
|
|
|
IKBKAP
|
[NCBI]
|
2.87843e-05
|
|
|
APOE
|
[NCBI]
|
2.79675e-05
|
|
|
HIDS
|
[NCBI]
|
2.78386e-05
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
2.78386e-05
|
|
|
PNDM
|
[NCBI]
|
2.78386e-05
|
|
|
uniparental disomy, paternal, chromosome 14
|
[NCBI]
|
2.78386e-05
|
|
|
PBT
|
[NCBI]
|
2.78386e-05
|
|
|
erythrocytosis, familial, 2
|
[NCBI]
|
2.78386e-05
|
|
|
mitochondrial complex iii deficiency
|
[NCBI]
|
2.78386e-05
|
|
|
TSD
|
[NCBI]
|
2.77119e-05
|
|
|
NQO1
|
[NCBI]
|
2.73453e-05
|
|
|
pyruvate carboxylase deficiency
|
[NCBI]
|
2.73409e-05
|
|
|
VDR
|
[NCBI]
|
2.70805e-05
|
|
|
TNFRSF6
|
[NCBI]
|
2.69675e-05
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
2.69675e-05
|
|
|
CTSC
|
[NCBI]
|
2.69675e-05
|
|
|
GALT
|
[NCBI]
|
2.63542e-05
|
|
|
PPT1
|
[NCBI]
|
2.63542e-05
|
|
|
TPI1
|
[NCBI]
|
2.63542e-05
|
|
|
LDLRAP1
|
[NCBI]
|
2.60526e-05
|
|
|
SPI1
|
[NCBI]
|
2.60526e-05
|
|
|
F3
|
[NCBI]
|
2.53967e-05
|
|
|
IFNA1
|
[NCBI]
|
2.52258e-05
|
|
|
LIG4
|
[NCBI]
|
2.48804e-05
|
|
|
TNFRSF10C
|
[NCBI]
|
2.48804e-05
|
|
|
DPYD
|
[NCBI]
|
2.48804e-05
|
|
|
DRD3
|
[NCBI]
|
2.48804e-05
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
2.41066e-05
|
|
|
hyperprolinemia, type ii
|
[NCBI]
|
2.39296e-05
|
|
|
amme complex
|
[NCBI]
|
2.39296e-05
|
|
|
WT5
|
[NCBI]
|
2.39296e-05
|
|
|
DYT1
|
[NCBI]
|
2.38522e-05
|
|
|
APAF1
|
[NCBI]
|
2.38093e-05
|
|
|
PEPA
|
[NCBI]
|
2.38093e-05
|
|
|
MOS
|
[NCBI]
|
2.38093e-05
|
|
|
HLA-G
|
[NCBI]
|
2.38093e-05
|
|
|
CTGF
|
[NCBI]
|
2.33609e-05
|
|
|
ADCYAP1
|
[NCBI]
|
2.3348e-05
|
|
|
RAG2
|
[NCBI]
|
2.28242e-05
|
|
|
SELP
|
[NCBI]
|
2.28242e-05
|
|
|
EPB41
|
[NCBI]
|
2.28242e-05
|
|
|
DBT
|
[NCBI]
|
2.28242e-05
|
|
|
IGF2
|
[NCBI]
|
2.26056e-05
|
|
|
WAS
|
[NCBI]
|
2.26056e-05
|
|
|
RFC3
|
[NCBI]
|
2.21729e-05
|
|
|
S5
|
[NCBI]
|
2.21729e-05
|
|
|
BCL6B
|
[NCBI]
|
2.21729e-05
|
|
|
FGF12
|
[NCBI]
|
2.21729e-05
|
|
|
IRTF1
|
[NCBI]
|
2.21729e-05
|
|
|
C9ORF26
|
[NCBI]
|
2.21729e-05
|
|
|
DDX1
|
[NCBI]
|
2.21729e-05
|
|
|
EPHB6
|
[NCBI]
|
2.21729e-05
|
|
|
SLC7A6
|
[NCBI]
|
2.21729e-05
|
|
|
STAG1
|
[NCBI]
|
2.21729e-05
|
|
|
TGFBRAP1
|
[NCBI]
|
2.21729e-05
|
|
|
PDSS1
|
[NCBI]
|
2.21729e-05
|
|
|
CTH
|
[NCBI]
|
2.21729e-05
|
|
|
ets transcription factor tel2
|
[NCBI]
|
2.21729e-05
|
|
|
SIRPG
|
[NCBI]
|
2.21729e-05
|
|
|
PKP4
|
[NCBI]
|
2.21729e-05
|
|
|
DNAH8
|
[NCBI]
|
2.21729e-05
|
|
|
TRSP
|
[NCBI]
|
2.21729e-05
|
|
|
EDG6
|
[NCBI]
|
2.21729e-05
|
|
|
SP140
|
[NCBI]
|
2.21729e-05
|
|
|
MAAT1
|
[NCBI]
|
2.21729e-05
|
|
|
TOR2A
|
[NCBI]
|
2.21729e-05
|
|
|
MUC3B
|
[NCBI]
|
2.21729e-05
|
|
|
S6
|
[NCBI]
|
2.21729e-05
|
|
|
g protein-coupled inward rectifier potassium channel
|
[NCBI]
|
2.21729e-05
|
|
|
GPR1
|
[NCBI]
|
2.21729e-05
|
|
|
PMVK
|
[NCBI]
|
2.21729e-05
|
|
|
SP100
|
[NCBI]
|
2.21729e-05
|
|
|
HOXB1
|
[NCBI]
|
2.21729e-05
|
|
|
WBSCR1
|
[NCBI]
|
2.21729e-05
|
|
|
DNAH1
|
[NCBI]
|
2.21729e-05
|
|
|
SMTN
|
[NCBI]
|
2.21729e-05
|
|
|
ARVCF
|
[NCBI]
|
2.21729e-05
|
|
|
abl interactor 2
|
[NCBI]
|
2.21729e-05
|
|
|
FEA
|
[NCBI]
|
2.21729e-05
|
|
|
FKBP3
|
[NCBI]
|
2.21729e-05
|
|
|
STAG2
|
[NCBI]
|
2.21729e-05
|
|
|
CD5L
|
[NCBI]
|
2.21729e-05
|
|
|
HOXB6
|
[NCBI]
|
2.21729e-05
|
|
|
TOR1B
|
[NCBI]
|
2.21729e-05
|
|
|
RAP1GA1
|
[NCBI]
|
2.21729e-05
|
|
|
LAIR2
|
[NCBI]
|
2.21729e-05
|
|
|
CD300LG
|
[NCBI]
|
2.21729e-05
|
|
|
ZNF288
|
[NCBI]
|
2.21729e-05
|
|
|
GFPT2
|
[NCBI]
|
2.21729e-05
|
|
|
SPAG8
|
[NCBI]
|
2.21729e-05
|
|
|
COPS3
|
[NCBI]
|
2.21729e-05
|
|
|
NMI
|
[NCBI]
|
2.21729e-05
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
2.2136e-05
|
|
|
H4FN
|
[NCBI]
|
2.19131e-05
|
|
|
GALK1
|
[NCBI]
|
2.19131e-05
|
|
|
THY1
|
[NCBI]
|
2.19131e-05
|
|
|
TAZ
|
[NCBI]
|
2.19131e-05
|
|
|
APOB
|
[NCBI]
|
2.16063e-05
|
|
|
FGF7
|
[NCBI]
|
2.14667e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
2.14375e-05
|
|
|
GSTM1
|
[NCBI]
|
2.10665e-05
|
|
|
MVK
|
[NCBI]
|
2.10665e-05
|
|
|
ACY1
|
[NCBI]
|
2.10665e-05
|
|
|
FCGR3A
|
[NCBI]
|
2.10665e-05
|
|
|
xx male syndrome
|
[NCBI]
|
2.07034e-05
|
|
|
DFNA9
|
[NCBI]
|
2.07034e-05
|
|
|
ATLD
|
[NCBI]
|
2.07034e-05
|
|
|
SXI1
|
[NCBI]
|
2.07034e-05
|
|
|
RENS1
|
[NCBI]
|
2.07034e-05
|
|
|
LGMD1B
|
[NCBI]
|
2.07034e-05
|
|
|
IL7R
|
[NCBI]
|
2.02765e-05
|
|
|
CD40
|
[NCBI]
|
2.02765e-05
|
|
|
IL15
|
[NCBI]
|
2.02765e-05
|
|
|
TCF3
|
[NCBI]
|
2.02765e-05
|
|
|
HLF
|
[NCBI]
|
1.95366e-05
|
|
|
IL7
|
[NCBI]
|
1.95366e-05
|
|
|
EPHX1
|
[NCBI]
|
1.95366e-05
|
|
|
KITLG
|
[NCBI]
|
1.95198e-05
|
|
|
SCZD
|
[NCBI]
|
1.94494e-05
|
|
|
hyperglycerolemia
|
[NCBI]
|
1.9406e-05
|
|
|
DBA
|
[NCBI]
|
1.93878e-05
|
|
|
FTL
|
[NCBI]
|
1.88413e-05
|
|
|
CXCL13
|
[NCBI]
|
1.88413e-05
|
|
|
IRF1
|
[NCBI]
|
1.88413e-05
|
|
|
XPC
|
[NCBI]
|
1.88413e-05
|
|
|
SMPD1
|
[NCBI]
|
1.88413e-05
|
|
|
FOS
|
[NCBI]
|
1.88413e-05
|
|
|
CD47
|
[NCBI]
|
1.88233e-05
|
|
|
SIRT6
|
[NCBI]
|
1.84889e-05
|
|
|
P2RX5
|
[NCBI]
|
1.84889e-05
|
|
|
UBE2D2
|
[NCBI]
|
1.84889e-05
|
|
|
POU2F2
|
[NCBI]
|
1.84889e-05
|
|
|
ST3GAL6
|
[NCBI]
|
1.84889e-05
|
|
|
MT3
|
[NCBI]
|
1.84889e-05
|
|
|
IGHD
|
[NCBI]
|
1.84889e-05
|
|
|
lymphocyte cytosol polypeptide, 20-kd
|
[NCBI]
|
1.84889e-05
|
|
|
POLRMT
|
[NCBI]
|
1.84889e-05
|
|
|
CTNND2
|
[NCBI]
|
1.84889e-05
|
|
|
FAU
|
[NCBI]
|
1.84889e-05
|
|
|
XCL2
|
[NCBI]
|
1.84889e-05
|
|
|
SQLE
|
[NCBI]
|
1.84889e-05
|
|
|
PTPN7
|
[NCBI]
|
1.84889e-05
|
|
|
EPHA3
|
[NCBI]
|
1.84889e-05
|
|
|
CYLN2
|
[NCBI]
|
1.84889e-05
|
|
|
DOCK10
|
[NCBI]
|
1.84889e-05
|
|
|
RETNLB
|
[NCBI]
|
1.84889e-05
|
|
|
RND1
|
[NCBI]
|
1.84889e-05
|
|
|
AOC3
|
[NCBI]
|
1.84889e-05
|
|
|
CD53
|
[NCBI]
|
1.84889e-05
|
|
|
SIX4
|
[NCBI]
|
1.84889e-05
|
|
|
DPP8
|
[NCBI]
|
1.84889e-05
|
|
|
NUP62
|
[NCBI]
|
1.84889e-05
|
|
|
COPG2
|
[NCBI]
|
1.84889e-05
|
|
|
IPW
|
[NCBI]
|
1.84889e-05
|
|
|
BYSL
|
[NCBI]
|
1.84889e-05
|
|
|
RARG
|
[NCBI]
|
1.84889e-05
|
|
|
GATM
|
[NCBI]
|
1.84889e-05
|
|
|
DOCK11
|
[NCBI]
|
1.84889e-05
|
|
|
SEA
|
[NCBI]
|
1.84889e-05
|
|
|
MAN2A2
|
[NCBI]
|
1.84889e-05
|
|
|
HUS1
|
[NCBI]
|
1.84889e-05
|
|
|
SIGLEC8
|
[NCBI]
|
1.84889e-05
|
|
|
MAN2C1
|
[NCBI]
|
1.84889e-05
|
|
|
UQCRB
|
[NCBI]
|
1.84889e-05
|
|
|
DNAH12
|
[NCBI]
|
1.84889e-05
|
|
|
RND3
|
[NCBI]
|
1.84889e-05
|
|
|
XCR1
|
[NCBI]
|
1.84889e-05
|
|
|
NKX2C
|
[NCBI]
|
1.84889e-05
|
|
|
PARL
|
[NCBI]
|
1.84889e-05
|
|
|
KCNB1
|
[NCBI]
|
1.84889e-05
|
|
|
CLEC2D
|
[NCBI]
|
1.84889e-05
|
|
|
HGD
|
[NCBI]
|
1.84889e-05
|
|
|
DTX1
|
[NCBI]
|
1.84889e-05
|
|
|
AMD1
|
[NCBI]
|
1.84889e-05
|
|
|
POLA
|
[NCBI]
|
1.84889e-05
|
|
|
SLC6A1
|
[NCBI]
|
1.84889e-05
|
|
|
ERAS
|
[NCBI]
|
1.84889e-05
|
|
|
FLII
|
[NCBI]
|
1.84889e-05
|
|
|
HCK
|
[NCBI]
|
1.84889e-05
|
|
|
ATR
|
[NCBI]
|
1.81862e-05
|
|
|
succinyl-coa:3-oxoacid coa transferase deficiency
|
[NCBI]
|
1.79879e-05
|
|
|
ARH
|
[NCBI]
|
1.79879e-05
|
|
|
HBFQTL1
|
[NCBI]
|
1.79879e-05
|
|
|
SCAR1
|
[NCBI]
|
1.79879e-05
|
|
|
carnitine palmitoyltransferase i deficiency
|
[NCBI]
|
1.79879e-05
|
|
|
leiomyomatosis and renal cell cancer, hereditary
|
[NCBI]
|
1.79879e-05
|
|
|
hypoparathyroidism, sensorineural deafness, and renal disease
|
[NCBI]
|
1.79879e-05
|
|
|
adenosine deaminase, elevated, hemolytic anemia due to
|
[NCBI]
|
1.79879e-05
|
|
|
CMT2A2
|
[NCBI]
|
1.79879e-05
|
|
|
XPF
|
[NCBI]
|
1.79879e-05
|
|
|
homocystinuria
|
[NCBI]
|
1.77524e-05
|
|
|
LNS
|
[NCBI]
|
1.76123e-05
|
|
|
GLO1
|
[NCBI]
|
1.75671e-05
|
|
|
CMH
|
[NCBI]
|
1.74399e-05
|
|
|
hemophilia a
|
[NCBI]
|
1.74129e-05
|
|
|
GHR
|
[NCBI]
|
1.70441e-05
|
|
|
SMN2
|
[NCBI]
|
1.69808e-05
|
|
|
IFNGR1
|
[NCBI]
|
1.69808e-05
|
|
|
PTHLH
|
[NCBI]
|
1.69332e-05
|
|
|
JAK3
|
[NCBI]
|
1.6758e-05
|
|
|
CHH
|
[NCBI]
|
1.67466e-05
|
|
|
SRF
|
[NCBI]
|
1.67341e-05
|
|
|
TF
|
[NCBI]
|
1.64878e-05
|
|
|
MAGEA4
|
[NCBI]
|
1.61261e-05
|
|
|
MLLT1
|
[NCBI]
|
1.61261e-05
|
|
|
EIF2B3
|
[NCBI]
|
1.61261e-05
|
|
|
PTGDR
|
[NCBI]
|
1.61261e-05
|
|
|
CD200R1
|
[NCBI]
|
1.61261e-05
|
|
|
MADCAM1
|
[NCBI]
|
1.61261e-05
|
|
|
IL10RA
|
[NCBI]
|
1.61261e-05
|
|
|
GPR2
|
[NCBI]
|
1.61261e-05
|
|
|
MAT2A
|
[NCBI]
|
1.61261e-05
|
|
|
TROAP
|
[NCBI]
|
1.61261e-05
|
|
|
FANCF
|
[NCBI]
|
1.61261e-05
|
|
|
ACTG2
|
[NCBI]
|
1.61261e-05
|
|
|
CCL15
|
[NCBI]
|
1.61261e-05
|
|
|
RFC2
|
[NCBI]
|
1.61261e-05
|
|
|
NUCB1
|
[NCBI]
|
1.61261e-05
|
|
|
PARP2
|
[NCBI]
|
1.61261e-05
|
|
|
TIMM13
|
[NCBI]
|
1.61261e-05
|
|
|
HCCS
|
[NCBI]
|
1.61261e-05
|
|
|
prostaglandin d2 synthase, hematopoietic
|
[NCBI]
|
1.61261e-05
|
|
|
CLN2
|
[NCBI]
|
1.61261e-05
|
|
|
CHE2
|
[NCBI]
|
1.61261e-05
|
|
|
RAD23A
|
[NCBI]
|
1.61261e-05
|
|
|
RASSF5
|
[NCBI]
|
1.61261e-05
|
|
|
ADRM1
|
[NCBI]
|
1.61261e-05
|
|
|
RFC4
|
[NCBI]
|
1.61261e-05
|
|
|
ITIH2
|
[NCBI]
|
1.61261e-05
|
|
|
ELAVL1
|
[NCBI]
|
1.61261e-05
|
|
|
CD5
|
[NCBI]
|
1.61261e-05
|
|
|
EIF2B2
|
[NCBI]
|
1.61261e-05
|
|
|
SH3KBP1
|
[NCBI]
|
1.61261e-05
|
|
|
PRSS15
|
[NCBI]
|
1.61261e-05
|
|
|
EIF3A
|
[NCBI]
|
1.61261e-05
|
|
|
SYBL1
|
[NCBI]
|
1.61261e-05
|
|
|
PMAIP1
|
[NCBI]
|
1.61261e-05
|
|
|
GPC1
|
[NCBI]
|
1.61261e-05
|
|
|
SNX27
|
[NCBI]
|
1.61261e-05
|
|
|
LSAMP
|
[NCBI]
|
1.61261e-05
|
|
|
antigen defined by monoclonal antibody f10.44.2
|
[NCBI]
|
1.61261e-05
|
|
|
ATXN10
|
[NCBI]
|
1.61261e-05
|
|
|
TYRO3
|
[NCBI]
|
1.61261e-05
|
|
|
MYADM
|
[NCBI]
|
1.61261e-05
|
|
|
GNAI2
|
[NCBI]
|
1.61261e-05
|
|
|
WAPAL
|
[NCBI]
|
1.61261e-05
|
|
|
CDK4
|
[NCBI]
|
1.60588e-05
|
|
|
GLA
|
[NCBI]
|
1.58953e-05
|
|
|
PRKDC
|
[NCBI]
|
1.58953e-05
|
|
|
SMS
|
[NCBI]
|
1.58644e-05
|
|
|
XPA
|
[NCBI]
|
1.57205e-05
|
|
|
EBS2
|
[NCBI]
|
1.56686e-05
|
|
|
ISS
|
[NCBI]
|
1.56686e-05
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
1.56686e-05
|
|
|
DMD
|
[NCBI]
|
1.55262e-05
|
|
|
CD59
|
[NCBI]
|
1.53913e-05
|
|
|
EMD
|
[NCBI]
|
1.53913e-05
|
|
|
FH
|
[NCBI]
|
1.53913e-05
|
|
|
ABCC1
|
[NCBI]
|
1.46686e-05
|
|
|
CD8A
|
[NCBI]
|
1.44508e-05
|
|
|
LILRA2
|
[NCBI]
|
1.43907e-05
|
|
|
CTNND1
|
[NCBI]
|
1.43907e-05
|
|
|
EIF2B4
|
[NCBI]
|
1.43907e-05
|
|
|
RFXAP
|
[NCBI]
|
1.43907e-05
|
|
|
BIRC7
|
[NCBI]
|
1.43907e-05
|
|
|
AZGP1
|
[NCBI]
|
1.43907e-05
|
|
|
XRCC3
|
[NCBI]
|
1.43907e-05
|
|
|
C1QBP
|
[NCBI]
|
1.43907e-05
|
|
|
b-cell rag-associated gene
|
[NCBI]
|
1.43907e-05
|
|
|
ERV1
|
[NCBI]
|
1.43907e-05
|
|
|
SH2B3
|
[NCBI]
|
1.43907e-05
|
|
|
TROVE2
|
[NCBI]
|
1.43907e-05
|
|
|
all1-fused gene from chromosome 15q14
|
[NCBI]
|
1.43907e-05
|
|
|
SLC27A2
|
[NCBI]
|
1.43907e-05
|
|
|
PTMA
|
[NCBI]
|
1.43907e-05
|
|
|
FUCA2
|
[NCBI]
|
1.43907e-05
|
|
|
NDUFS8
|
[NCBI]
|
1.43907e-05
|
|
|
HELLS
|
[NCBI]
|
1.43907e-05
|
|
|
AKT3
|
[NCBI]
|
1.43907e-05
|
|
|
TPSB2
|
[NCBI]
|
1.43907e-05
|
|
|
GANC
|
[NCBI]
|
1.43907e-05
|
|
|
SLC35C1
|
[NCBI]
|
1.43907e-05
|
|
|
LILRB2
|
[NCBI]
|
1.43907e-05
|
|
|
MAN2A1
|
[NCBI]
|
1.43907e-05
|
|
|
ALDH5A1
|
[NCBI]
|
1.43907e-05
|
|
|
ABAT
|
[NCBI]
|
1.43907e-05
|
|
|
LILRB4
|
[NCBI]
|
1.43907e-05
|
|
|
GABRA3
|
[NCBI]
|
1.43907e-05
|
|
|
C20ORF1
|
[NCBI]
|
1.43907e-05
|
|
|
HK2
|
[NCBI]
|
1.43907e-05
|
|
|
SLC7A7
|
[NCBI]
|
1.43907e-05
|
|
|
SORL1
|
[NCBI]
|
1.43907e-05
|
|
|
MMP10
|
[NCBI]
|
1.43907e-05
|
|
|
GPR14
|
[NCBI]
|
1.43907e-05
|
|
|
TAP2
|
[NCBI]
|
1.43907e-05
|
|
|
LALBA
|
[NCBI]
|
1.43907e-05
|
|
|
AXL
|
[NCBI]
|
1.43907e-05
|
|
|
ITGAE
|
[NCBI]
|
1.43907e-05
|
|
|
CD69
|
[NCBI]
|
1.43907e-05
|
|
|
ITIH3
|
[NCBI]
|
1.43907e-05
|
|
|
GNRH1
|
[NCBI]
|
1.3944e-05
|
|
|
porphyria, congenital erythropoietic
|
[NCBI]
|
1.36659e-05
|
|
|
SCZD2
|
[NCBI]
|
1.36659e-05
|
|
|
HMI
|
[NCBI]
|
1.35896e-05
|
|
|
OSM
|
[NCBI]
|
1.32305e-05
|
|
|
DNMT3B
|
[NCBI]
|
1.31854e-05
|
|
|
GAMT
|
[NCBI]
|
1.31854e-05
|
|
|
CLTA
|
[NCBI]
|
1.30249e-05
|
|
|
PCDH8
|
[NCBI]
|
1.30249e-05
|
|
|
FEN1
|
[NCBI]
|
1.30249e-05
|
|
|
DLX5
|
[NCBI]
|
1.30249e-05
|
|
|
LTB
|
[NCBI]
|
1.30249e-05
|
|
|
CD86
|
[NCBI]
|
1.30249e-05
|
|
|
PRLHR
|
[NCBI]
|
1.30249e-05
|
|
|
HAS1
|
[NCBI]
|
1.30249e-05
|
|
|
MUC3A
|
[NCBI]
|
1.30249e-05
|
|
|
TRMU
|
[NCBI]
|
1.30249e-05
|
|
|
PTPRE
|
[NCBI]
|
1.30249e-05
|
|
|
CASP10
|
[NCBI]
|
1.30249e-05
|
|
|
NPPB
|
[NCBI]
|
1.30249e-05
|
|
|
AIF1
|
[NCBI]
|
1.30249e-05
|
|
|
KLF7
|
[NCBI]
|
1.30249e-05
|
|
|
SIPA1
|
[NCBI]
|
1.30249e-05
|
|
|
HSD17B1
|
[NCBI]
|
1.30249e-05
|
|
|
CCR1
|
[NCBI]
|
1.30249e-05
|
|
|
ITGAM
|
[NCBI]
|
1.30249e-05
|
|
|
UBE2D1
|
[NCBI]
|
1.30249e-05
|
|
|
GPR3
|
[NCBI]
|
1.30249e-05
|
|
|
LAIR1
|
[NCBI]
|
1.30249e-05
|
|
|
ITIH1
|
[NCBI]
|
1.30249e-05
|
|
|
AES
|
[NCBI]
|
1.30249e-05
|
|
|
RAD23B
|
[NCBI]
|
1.30249e-05
|
|
|
LMNB2
|
[NCBI]
|
1.30249e-05
|
|
|
BTG1
|
[NCBI]
|
1.30249e-05
|
|
|
SDHB
|
[NCBI]
|
1.30249e-05
|
|
|
CDC25B
|
[NCBI]
|
1.30249e-05
|
|
|
CSPG4
|
[NCBI]
|
1.30249e-05
|
|
|
HPA-2
|
[NCBI]
|
1.30249e-05
|
|
|
HEXB
|
[NCBI]
|
1.27972e-05
|
|
|
USF1
|
[NCBI]
|
1.27972e-05
|
|
|
GPX1
|
[NCBI]
|
1.27972e-05
|
|
|
TCRG
|
[NCBI]
|
1.2424e-05
|
|
|
KRAS
|
[NCBI]
|
1.2424e-05
|
|
|
SOCS1
|
[NCBI]
|
1.2424e-05
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
1.2424e-05
|
|
|
TNFSF11
|
[NCBI]
|
1.21008e-05
|
|
|
GDXY
|
[NCBI]
|
1.20649e-05
|
|
|
XDH
|
[NCBI]
|
1.19861e-05
|
|
|
diabetes mellitus, insulin-resistant, with acanthosis nigricans
|
[NCBI]
|
1.19219e-05
|
|
|
HHS
|
[NCBI]
|
1.19219e-05
|
|
|
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
|
[NCBI]
|
1.19219e-05
|
|
|
SCZD4
|
[NCBI]
|
1.19219e-05
|
|
|
severe combined immunodeficiency with sensitivity to ionizing radiation
|
[NCBI]
|
1.19219e-05
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
1.19219e-05
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
1.19219e-05
|
|
|
aging
|
[NCBI]
|
1.19219e-05
|
|
|
THC2
|
[NCBI]
|
1.19219e-05
|
|
|
DMC
|
[NCBI]
|
1.19219e-05
|
|
|
CMT2A1
|
[NCBI]
|
1.19219e-05
|
|
|
bladder cancer
|
[NCBI]
|
1.19219e-05
|
|
|
VNN1
|
[NCBI]
|
1.19033e-05
|
|
|
KSR1
|
[NCBI]
|
1.19033e-05
|
|
|
LHX2
|
[NCBI]
|
1.19033e-05
|
|
|
CD83
|
[NCBI]
|
1.19033e-05
|
|
|
ZBTB32
|
[NCBI]
|
1.19033e-05
|
|
|
ADRB1
|
[NCBI]
|
1.19033e-05
|
|
|
BRD4
|
[NCBI]
|
1.19033e-05
|
|
|
DCLRE1C
|
[NCBI]
|
1.19033e-05
|
|
|
RFX5
|
[NCBI]
|
1.19033e-05
|
|
|
MC5R
|
[NCBI]
|
1.19033e-05
|
|
|
WASL
|
[NCBI]
|
1.19033e-05
|
|
|
tritanopia
|
[NCBI]
|
1.19033e-05
|
|
|
BCKDHA
|
[NCBI]
|
1.19033e-05
|
|
|
RPL7
|
[NCBI]
|
1.19033e-05
|
|
|
PTPRG
|
[NCBI]
|
1.19033e-05
|
|
|
ACTN4
|
[NCBI]
|
1.19033e-05
|
|
|
AMBP
|
[NCBI]
|
1.19033e-05
|
|
|
GNAT1
|
[NCBI]
|
1.19033e-05
|
|
|
GCLC
|
[NCBI]
|
1.19033e-05
|
|
|
RARB
|
[NCBI]
|
1.19033e-05
|
|
|
TRIP10
|
[NCBI]
|
1.19033e-05
|
|
|
PDE6G
|
[NCBI]
|
1.19033e-05
|
|
|
XRCC4
|
[NCBI]
|
1.19033e-05
|
|
|
CD6
|
[NCBI]
|
1.19033e-05
|
|
|
CCL3L1
|
[NCBI]
|
1.19033e-05
|
|
|
PSPH
|
[NCBI]
|
1.19033e-05
|
|
|
CCR9
|
[NCBI]
|
1.19033e-05
|
|
|
LILRB1
|
[NCBI]
|
1.19033e-05
|
|
|
BTD
|
[NCBI]
|
1.19033e-05
|
|
|
RTS
|
[NCBI]
|
1.17365e-05
|
|
|
IL2RA
|
[NCBI]
|
1.13857e-05
|
|
|
TSC2
|
[NCBI]
|
1.13857e-05
|
|
|
PKD2
|
[NCBI]
|
1.13857e-05
|
|
|
RUNX1
|
[NCBI]
|
1.10641e-05
|
|
|
TPSAB1
|
[NCBI]
|
1.09553e-05
|
|
|
HOXB5
|
[NCBI]
|
1.09553e-05
|
|
|
NAGLU
|
[NCBI]
|
1.09553e-05
|
|
|
IREB2
|
[NCBI]
|
1.09553e-05
|
|
|
ADCYAP1R1
|
[NCBI]
|
1.09553e-05
|
|
|
CTSE
|
[NCBI]
|
1.09553e-05
|
|
|
ELAVL4
|
[NCBI]
|
1.09553e-05
|
|
|
CD55
|
[NCBI]
|
1.09553e-05
|
|
|
CCNA2
|
[NCBI]
|
1.09553e-05
|
|
|
GPD2
|
[NCBI]
|
1.09553e-05
|
|
|
TNFSF13
|
[NCBI]
|
1.09553e-05
|
|
|
DEFA3
|
[NCBI]
|
1.09553e-05
|
|
|
RPL19
|
[NCBI]
|
1.09553e-05
|
|
|
NT5C
|
[NCBI]
|
1.09553e-05
|
|
|
MAP3K14
|
[NCBI]
|
1.09553e-05
|
|
|
IL10RB
|
[NCBI]
|
1.09553e-05
|
|
|
ADRA1B
|
[NCBI]
|
1.09553e-05
|
|
|
OPRL1
|
[NCBI]
|
1.09553e-05
|
|
|
PFKP
|
[NCBI]
|
1.09553e-05
|
|
|
HLCS
|
[NCBI]
|
1.09553e-05
|
|
|
TOP1
|
[NCBI]
|
1.09553e-05
|
|
|
PDCD2
|
[NCBI]
|
1.09553e-05
|
|
|
FCER2
|
[NCBI]
|
1.09553e-05
|
|
|
HTRA1
|
[NCBI]
|
1.09553e-05
|
|
|
ERCC4
|
[NCBI]
|
1.09553e-05
|
|
|
SMARCB1
|
[NCBI]
|
1.09553e-05
|
|
|
PTPN22
|
[NCBI]
|
1.09553e-05
|
|
|
SDHA
|
[NCBI]
|
1.09553e-05
|
|
|
TNFRSF18
|
[NCBI]
|
1.09553e-05
|
|
|
CCDC6
|
[NCBI]
|
1.09553e-05
|
|
|
PLEC1
|
[NCBI]
|
1.09553e-05
|
|
|
FOP
|
[NCBI]
|
1.08795e-05
|
|
|
SOD2
|
[NCBI]
|
1.07775e-05
|
|
|
PDHA1
|
[NCBI]
|
1.07537e-05
|
|
|
STAR
|
[NCBI]
|
1.0623e-05
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
1.04537e-05
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
1.04537e-05
|
|
|
CLN2
|
[NCBI]
|
1.03935e-05
|
|
|
dent disease 1
|
[NCBI]
|
1.03935e-05
|
|
|
HPC1
|
[NCBI]
|
1.03935e-05
|
|
|
propionic acidemia
|
[NCBI]
|
1.03935e-05
|
|
|
SMA2
|
[NCBI]
|
1.03935e-05
|
|
|
CRS1
|
[NCBI]
|
1.03935e-05
|
|
| |